Nyrada
Report prepared as part of ASX Small and Mid-Cap Conference - 14 September 2021.
Australian biotech news website, BiotechDispatch said Nyrada had reported "encouraging efficacy results" from an in vivo study involving its NYX-PCSK9i drug candidate.
Read more here